Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
73 studies found for:    arrhythmia OR atrial fibrillation OR ventricular fibrillation OR tachycardia OR bradycardia | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
21 Recruiting A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Coagulopathies;   Pulmonary Embolism
Interventions: Genetic: Genotype-guided;   Other: Standard-of-Care
22 Recruiting Risk of Oxygen During Cardiac Surgery Trial
Condition: Cardiac Surgery
Intervention: Drug: Oxygen
23 Recruiting Listening to Mom in the NICU: Neural, Clinical and Language Outcomes
Condition: Premature Birth
Interventions: Behavioral: Language Treatment;   Behavioral: Control Treatment
24 Recruiting A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes
Conditions: Long qt Syndrome;   Torsade de Pointes
Intervention:
25 Recruiting Cardiovascular Disease Protection Tissue
Condition: Myocardial Ischemia
Interventions: Procedure: Heart failure or coronary disease;   Procedure: Heart transplant patients;   Procedure: Orthotopic Heart Transplant Patients;   Procedure: Heart Surgery Patients;   Procedure: Blood Draw
26 Recruiting Genetics of QT Prolongation With Antiarrhythmics
Conditions: Long QT Syndrome;   Drug Toxicity
Intervention: Drug: Dofetilide and/or sotalol
27 Not yet recruiting NHLBI DIR LAMPOON Study: Intentional Laceration of the Anterior Mitral Leaflet to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Implantation
Condition: Mitral Valve Failure
Interventions: Device: Edwards SAPIEN 3 transcatheter heart valve;   Device: ASHI INTECC Astato XS 20
28 Recruiting CiPA Phase 1 ECG Biomarker Validation Study
Conditions: Drug-induced QT Prolongation;   Pharmacokinetics;   Pharmacodynamics
Interventions: Drug: Ranolazine;   Drug: Verapamil;   Drug: Lopinavir / Ritonavir;   Drug: Chloroquine;   Drug: Placebo;   Drug: Dofetilide and Diltiazem
29 Not yet recruiting Milrinone in Congenital Diaphragmatic Hernia
Conditions: Congenital Diaphragmatic Hernia;   Persistent Pulmonary Hypertension of the Newborn;   Hypoxemic Respiratory Failure;   Pulmonary Hypoplasia
Interventions: Drug: Milrinone;   Drug: Placebo (5% Dextrose)
30 Recruiting Rhode Island Diastolic Dysfunction - Heart Failure
Conditions: Heart Failure;   Cardiovascular Disease
Intervention: Drug: Kuvan
31 Not yet recruiting Low Versus High Transitional Oxygen Saturation Targets for Preterm Resuscitation in the Delivery Room
Condition: Oxidative Stress
Intervention: Other: Titration of oxygen during neonatal resuscitation
32 Recruiting The ENRGISE Pilot Study
Condition: Inflammation
Interventions: Dietary Supplement: Omega-3 fish oil;   Drug: Losartan;   Other: Placebo
33 Recruiting Preventing Sickle Cell Kidney Disease
Conditions: Anemia, Sickle Cell;   Sickle Cell Disease;   Kidney Disease;   Hypertension;   Proteinuria
Intervention: Drug: Losartan
34 Recruiting Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Conditions: Mild Tricuspid Regurgitation;   Moderate Tricuspid Regurgitation;   Tricuspid Regurgitation
Interventions: Procedure: TV Annuloplasty;   Procedure: MVS Alone
35 Recruiting Phase 1/2 Prospective Double-blind, Placebo-controlled Randomized Clinical Trial Using Losartan to Treat Grade II and III Hamstring Strains
Condition: Hamstring Injury
Interventions: Drug: Losartan;   Drug: placebo
36 Recruiting Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: Losartan;   Drug: Placebo
37 Recruiting DIG-HIF1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Digoxin
38 Recruiting Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: Losartan;   Radiation: Proton Beam Radiation
39 Recruiting Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: F-DOPA PET Scan;   Drug: Mifepristone;   Drug: Ga-DOTATATE;   Drug: Octreoscan;   Other: CT, MRI
40 Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: Pentetreotide;   Drug: 18-F-fluorodeoxyglucose;   Drug: (18F)-L-3,4-dihydroxyophenylalanine (18F-DOPA)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.